Access Programs
214 programsNZ Named Patient Supply
Framework: Medicines Act 1981 Section 29
Patient with serious or life-threatening condition, no registered alternative available
Named Patient Program14d
Oman Named Patient Program
Framework: MOH Oman Drug Regulations
Patient with serious or life-threatening condition, no registered alternative available
Named Patient Program30d
Pakistan Named Patient Program
Framework: DRAP Act 2012
Patient with serious or life-threatening condition, no registered alternative available
Named Patient Program30d
Palau Named Patient Program
Patient with serious or life-threatening condition, no registered alternative available
Named Patient Program60d
Panama Named Patient Program
Patient with serious or life-threatening condition, no registered alternative available
Named Patient Program30d
Papua New Guinea Named Patient Program
Framework: PNG Drug Regulation
Patient with serious or life-threatening condition, no registered alternative available
Named Patient Program30d
Paraguay Named Patient Program
Patient with serious or life-threatening condition, no registered alternative available
Named Patient Program30d
Peru Named Patient Program
Framework: General Health Law No. 26842
Patient with serious or life-threatening condition, no registered alternative available
Named Patient Program30d
Philippines Compassionate Special Permit
Framework: RA 9711 FDA Act 2009
Patient with serious or life-threatening condition, no registered alternative available
Compassionate Use21d
PMDA Sakigake Designation
Framework: PMDA Strategy of SAKIGAKE
First-in-world development in Japan for severe diseases, significant efficacy expected
EAP180d
Project Orbis FDA Oncology
Framework: FDA Oncology Center of Excellence Initiative
Novel cancer therapies under concurrent review by multiple regulatory agencies
Managed Access
Qatar Compassionate Use Program
Framework: MOPH Qatar Drug Regulations
Patient with serious or life-threatening condition, no registered alternative available
Compassionate Use21d
Russia Unregistered Drug Access Program
Framework: Federal Law No. 61-FZ
Patient with serious or life-threatening condition, no registered alternative available
Compassionate Use30d
Rwanda Named Patient Program
Framework: Rwanda Pharmacy Law
Patient with serious or life-threatening condition, no registered alternative available
Named Patient Program14d
Saint Kitts and Nevis Named Patient Program
Patient with serious or life-threatening condition, no registered alternative available
Named Patient Program45d
Saint Lucia Named Patient Program
Patient with serious or life-threatening condition, no registered alternative available
Named Patient Program45d
Saint Vincent and the Grenadines Named Patient Program
Patient with serious or life-threatening condition, no registered alternative available
Named Patient Program45d
Samoa Named Patient Program
Patient with serious or life-threatening condition, no registered alternative available
Named Patient Program60d
San Marino Named Patient Program (via EMA)
Framework: EU Directive 2001/83/EC
Patient with serious or life-threatening condition, no registered alternative available
Named Patient Program14d
Sao Tome and Principe Named Patient Program
Patient with serious or life-threatening condition, no registered alternative available
Named Patient Program60d
Saudi Arabia Named Patient Program
Framework: SFDA Drug Registration Rules
Patient with serious or life-threatening condition, no registered alternative available
Named Patient Program21d
Senegal Named Patient Program
Patient with serious or life-threatening condition, no registered alternative available
Named Patient Program30d
Serbia Compassionate Use Program
Framework: Law on Medicines and Medical Devices
Patient with serious or life-threatening condition, no registered alternative available
Compassionate Use30d
Seychelles Named Patient Program
Patient with serious or life-threatening condition, no registered alternative available
Named Patient Program30d
Sierra Leone Named Patient Program
Patient with serious or life-threatening condition, no registered alternative available
Named Patient Program45d